About
BIOVIA is an enterprise-grade scientific R&D platform developed by Dassault Systèmes that integrates generative AI, machine learning, and physics-based simulation to accelerate discovery across biological, chemical, and materials science domains. Built on the 3DEXPERIENCE platform, BIOVIA provides an open, collaborative environment where scientists can design molecules, formulate materials, and run virtual experiments without the time and resource costs of traditional wet-lab workflows. The platform spans six core disciplines: Biosciences (for life sciences R&D), Laboratory Informatics (to optimize lab productivity and compliance), Materials Science & Engineering (for in silico design), Scientific Informatics (to convert raw data into actionable knowledge), Regulatory Management (with structured content authoring), and Quality Management (AI-based end-to-end digital QMS). Key products within the portfolio include Discovery Studio for molecular modeling, Materials Studio for computational materials science, Pipeline Pilot for scientific data workflows, ONE Lab for electronic lab notebooks and data standardization, and Generative Therapeutics Design for next-generation drug discovery. BIOVIA's AI layer, Scientific AI, provides every scientist access to generative technology for faster hypothesis generation, virtual screening, and formulation development. The platform is trusted by leading pharmaceutical, biotech, chemical, and consumer goods companies globally.
Key Features
- Scientific Generative AI: Provides scientists with cutting-edge generative AI tools to design molecules, formulations, and materials faster, reducing reliance on physical experimentation.
- Virtual Twin Experiences: Enables virtual simulation of experiments and drug discovery workflows using physics-based modeling combined with AI, minimizing materials consumption and accelerating timelines.
- Unified Laboratory Informatics: ONE Lab and Pipeline Pilot standardize lab data capture electronically, ensuring AI-ready, high-quality datasets and full regulatory compliance across all lab operations.
- End-to-End Drug Discovery Suite: Combines AI/ML, physics-based 3D molecular modeling, and lab informatics in a single environment for small molecule and biotherapeutics design and optimization.
- AI-Based Quality Management: Delivers digital, AI-driven quality management workflows to ensure product safety, batch release readiness, and regulatory compliance across the product lifecycle.
Use Cases
- Pharmaceutical companies accelerating small molecule drug discovery by combining AI-based virtual screening with 3D molecular modeling to identify and optimize lead candidates before synthesis.
- Biotech firms designing and optimizing biotherapeutics such as antibodies and gene therapies using generative AI and physics-based simulation to reduce wet-lab iteration cycles.
- Consumer goods and specialty chemical companies streamlining formulation and recipe development workflows with AI-powered suggestions and virtual testing environments.
- Quality assurance teams in regulated industries automating digital QC lab workflows for faster, data-driven batch release decisions while maintaining compliance with GMP standards.
- Materials science researchers performing in silico design and property prediction for novel materials, minimizing physical experimentation and accelerating time to commercialization.
Pros
- Comprehensive Scientific Coverage: Covers the full R&D lifecycle from molecular design and formulation through regulatory submission and quality management in a single unified platform.
- Proven Enterprise Adoption: Trusted by thousands of leading pharmaceutical, biotech, and materials companies globally, with documented customer success stories showing measurable efficiency gains.
- AI + Physics Integration: Uniquely combines generative AI with physics-based simulation, offering more scientifically rigorous predictions than pure ML approaches.
- Open Collaborative Platform: Built on the 3DEXPERIENCE platform, enabling cross-team collaboration and data sharing across disciplines and geographies.
Cons
- Enterprise Pricing Barrier: BIOVIA is a premium enterprise solution with no publicly available free tier, making it inaccessible to small labs, startups, or individual researchers with limited budgets.
- Steep Learning Curve: The breadth of the platform—spanning multiple disciplines and products—can be overwhelming, requiring significant onboarding, training, and change management investment.
- Implementation Complexity: Full deployment and integration with existing laboratory systems and regulatory workflows can be time-consuming and may require professional services support.
Frequently Asked Questions
What industries does BIOVIA serve?
BIOVIA primarily serves Life Sciences & Healthcare, Consumer Packaged Goods & Retail, Infrastructure, Energy & Materials, and Transportation & Mobility industries, with a strong focus on pharmaceutical, biotech, and advanced materials companies.
What is the 3DEXPERIENCE BIOVIA platform?
3DEXPERIENCE BIOVIA is Dassault Systèmes' cloud-based collaborative platform that hosts all BIOVIA applications, enabling scientists across disciplines to share data, collaborate in real time, and access AI-powered tools from a single unified environment.
How does BIOVIA use generative AI in drug discovery?
BIOVIA's Generative Therapeutics Design product uses generative AI models combined with physics-based workflows to propose novel molecular structures for both small molecule and biologic therapeutics, significantly speeding up the hit identification and optimization phases of drug discovery.
What is ONE Lab and how does it support AI readiness?
ONE Lab is BIOVIA's electronic lab notebook and lab execution system that captures experimental data electronically in a standardized, unified data model, ensuring the high-quality, structured datasets needed to train and run AI models effectively in a laboratory setting.
Is BIOVIA available as a cloud solution?
Yes, BIOVIA is available on the cloud-based 3DEXPERIENCE platform, as well as on-premise deployments for organizations with specific data residency or security requirements. Dassault Systèmes also offers Contract Research Services for companies wanting managed access.
